Auspex Pharmaceuticals, Inc.: key financial figures for fiscal year 2014 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2014)
- -$59.5M
- Total Assets (FY2014)
- $151.1M
- Total Equity (FY2014)
- $124.9M
- Cash Flows from Operating Activities (FY2014)
- -$42.9M
Source: Auspex Pharmaceuticals, Inc. 10-K filing (FY2014). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
